Rejected from BMJ Open? How to Choose Your Next Journal

If the decision came before external review, do not infer a numerical desk-rejection rate or assume a single reason. Compare the stated rationale with the journal's current scope, article-type rules, and required declarations. A scope mismatch calls for retargeting; a missing file or reporting item calls for a package repair before any new submission.

If editor or reviewer feedback identifies a design, analysis, control, sample-size, or confounding problem, treat it as a manuscript problem until the evidence says otherwise. A new title does not make the same method more defensible.

If the letter challenges the conclusion, map every conclusion sentence to the result, uncertainty, and design that supports it. Observational evidence, a pilot study, and a completed trial justify different language. This repair should precede a new journal search.

For reporting concerns, identify the applicable guideline, locate each required item in the manuscript, and check the next journal's current instructions. Do not assume a checklist or declaration rule transfers unchanged between journals.

Before choosing your next journal, a BMJ Open manuscript fit check can tell you whether the issue was scope or something more fundamental to address first.

1. PLOS ONE

PLOS ONE can be a candidate after a BMJ Open rejection when the study is methodologically sound and the revised paper fits its current multidisciplinary scope. Confirm the live article-type, publication-fee, reporting, and editorial criteria before treating it as a destination. It is not a default solution for unresolved methods or evidence problems.

Best for: Methodologically sound papers with incremental or confirmatory results, any clinical discipline.

Think twice if: the manuscript still has an unresolved design, reporting, or conclusion problem.

2. BMC Public Health

For public-health and epidemiology papers, BMC Public Health can be a candidate when the intended reader and manuscript contribution are clearly population-health focused. Do not assume a different journal will take a paper without repairing the decision-letter concerns.

Best for: Public health research, community interventions, health policy, epidemiological studies.

Think twice if: the article's main audience is a clinical specialty rather than population health.

3. BMC Medicine

This is a different and potentially more selective route, not a safety option. Consider BMC Medicine only when the revised work has the general clinical significance, evidence, and article fit that its current editorial criteria require.

Best for: Strong clinical trials, high-quality systematic reviews, and practice-changing research.

Think twice if: the contribution is narrow, preliminary, or not supported by general-medicine-level evidence.

4. JMIR (Journal of Medical Internet Research)

If the manuscript concerns digital health, telemedicine, mobile health, or health informatics, identify the JMIR title whose current scope and article type match the study. Technology framing alone does not resolve a methods, analysis, or reporting problem.

Best for: Digital health interventions, telemedicine, health apps, wearable technology in clinical care.

Think twice if: technology is incidental to the study or the selected title does not accept the manuscript's article type.

5. International Journal of Environmental Research and Public Health

For environmental epidemiology and occupational-health work, consider an environmental-health destination only when that audience is central to the revised paper. Check the current journal status, scope, publisher, author instructions, and indexing directly before submission.

Best for: Environmental epidemiology, occupational health, global public health, health disparities.

Think twice if: the environmental-health route is being used only to avoid repairing a clinical or methodological concern.

6. Medicine (Lippincott Williams & Wilkins)

For a case report, case series, small observational study, or narrow clinical question, consider a title whose current article types and readership match that form of evidence. Do not use a presumed acceptance rate or fee as a substitute for checking the current author instructions.

Best for: Case reports, case series, small observational studies, narrative reviews.

Think twice if: the article type, evidence standard, or audience does not match the receiving journal's current instructions.

7. BMJ Open Quality

If the submission focused on quality improvement, patient safety, or healthcare delivery, assess BMJ Open Quality or another appropriate implementation venue against its current scope. Follow an explicit journal-transfer recommendation in the decision letter only after checking the transfer terms and the receiving journal's requirements.

Best for: Quality improvement projects, patient safety studies, healthcare process evaluations.

Think twice if: the work is conventional observational research rather than a defined improvement or implementation project.

Desk rejected for a reporting or package concern? Identify the relevant reporting guideline, repair the manuscript and submission files, then check the next journal's current requirements. Do not assume the same checklist applies unchanged.

Rejected for a novelty or contribution concern? Separate a framing problem from an evidence problem. If the contribution is narrower but still supported, look for a specialty audience that values that question; if the evidence is incomplete, revise before retargeting.

Rejected for an underpowered study? Decide whether additional data, a narrower estimand, or an explicitly exploratory framing is scientifically defensible. A different journal cannot convert an underpowered confirmatory claim into a supported result.

Rejected for methodology after full review? Fix every issue the reviewers identified before going anywhere. Methodological problems won't disappear at a different journal. If the statistical analysis needs reworking, get a biostatistician involved.

Rejected for scope? Route by the paper's real audience and contribution, such as population health, environmental health, digital health, a clinical specialty, or quality improvement. Verify the new destination's current scope rather than relying on a list position.

Complete your reporting checklist. Download the appropriate checklist (EQUATOR Network has all of them) and fill it out before submitting anywhere. Many rejections from BMJ Open and similar journals are entirely preventable with proper reporting.

Tone down your conclusions. If the reviewers said you overstated your findings, rewrite your conclusions to match the study design. Observational studies can't prove causation. Pilot trials can't demonstrate efficacy. Saying what the study actually shows, rather than what you wish it showed, makes the paper stronger at every journal.

Address every reviewer comment. Even if you're submitting to a different journal, the BMJ Open reviewers gave you a free consultation. Their feedback is probably similar to what the next journal's reviewers will say. Fix everything they flagged.

Consider a biostatistician. If statistical analysis was cited as a weakness, invest in a formal statistical review. Many institutions offer free biostatistics consultation for faculty, and the improvement in manuscript quality is substantial.

Don't just change the cover letter and send the same paper to the next journal. Run your revised manuscript through a BMJ Open manuscript scope and readiness check to catch formatting gaps, reporting compliance issues, and scope mismatches before reviewers see them. The fastest path to acceptance starts with fixing the problems, not just finding a different set of reviewers.

Do not submit the same manuscript to another journal while a transfer, appeal, or active submission is still pending. Resolve or withdraw the existing route first, then follow the receiving journal's current submission instructions.

In our pre-submission review work with authors revising after a BMJ Open decision, we do not treat the destination list as the first task. We first convert the letter, reports, and manuscript into a small evidence ledger: what the editor actually decided, which manuscript component each concern reaches, what repair is possible, and which concern would still matter at the next journal. This is an author-side workflow observation, not access to BMJ Open's internal decision records and not a prediction that a revised paper will be accepted anywhere.

The BMJ Open scope-versus-evidence split. A short BMJ Open decision can sound like a scope rejection while also pointing to a missing methodological explanation. We ask the authors to mark every sentence in the letter as either audience fit, article type, reporting package, design, analysis, or claim concern. The abstract, introduction, and cover letter can be retargeted when the audience is wrong. A missing control, unexplained sample-size limitation, or unsupported conclusion belongs in the manuscript and must be repaired before journal selection.

The decision-letter-to-manuscript map. A useful response is not a general promise to "address reviewer feedback." For each finding, we identify the exact abstract sentence, methods paragraph, result, figure, table, reference, supplement, ethics statement, or data-availability statement that needs work. This prevents a common failure mode: authors revise the cover letter and discussion while leaving the main evidence or reporting gap unchanged. The output is a revision ledger with a named owner, supporting evidence, and a stop condition when the requested repair cannot be made honestly.

The false-transfer shortcut. A transfer invitation or a list of possible venues is not evidence that the paper now fits a receiving journal. For a BMJ Open manuscript, we compare the revised article type, central audience, study design, methods, figures, and conclusion with the receiving journal's current public scope. We also recheck whether the authors can meet the new journal's reporting, ethics, data, and file requirements. The decision is to transfer only when that evidence aligns; otherwise the authors revise further, appeal through the documented process, or choose a fresh submission route.

The metric-led retargeting trap. Authors sometimes reach for a lower impact factor, a claimed acceptance rate, or a fast timeline after a rejection. Those values cannot tell them whether the next editor will accept the same evidence. We instead ask what reader needs the result, what claim is supported by the main figure or table, what limitation remains visible, and whether the target's article types genuinely include the work. That produces a defensible route even when current public journal metrics change.

For each pattern, the practical test is concrete: the decision letter must map to a manuscript location, the repair must have an evidence owner, and the proposed destination must pass a current scope-and-package check. That is the work a ranking list cannot perform.

1. Save the decision letter and reviewer reports, then mark each concern as scope, reporting, methods, analysis, evidence, claim, or package.
2. Build a revision ledger that links every concern to an abstract sentence, methods paragraph, result, figure, table, reference, supplement, or declaration.
3. Decide whether the evidence can be repaired honestly before choosing a new destination.
4. Compare the revised article type and audience with the current scope and author instructions for no more than three candidate journals.
5. Resolve any active transfer or appeal route before starting a fresh submission.

Resubmit to the same tier if:

• Reviewers praised the science but identified fixable issues

• The rejection letter mentioned "consider resubmission after revision"

• You can address every concern within 2-3 months

• No competing paper has appeared since your submission

Move to a different journal if:

• The rejection cited scope mismatch, not quality

• Multiple reviewers questioned novelty or significance

• Your timeline needs a decision within 2-3 months

• A specialist journal's readership would value the work more

Reframe before resubmitting anywhere if:

• Reviewers found fundamental methodology concerns

• The narrative needs restructuring, not just polishing

• New experiments or analyses are needed

• The rejection exposed a gap between claims and evidence

For manuscripts targeting BMJ Open, four patterns generate the most consistent desk rejections worth knowing before resubmission.

Methodological reporting gaps that prevent evaluation of scientific validity. When a decision letter identifies incomplete reporting, trace the concern to the relevant manuscript section and applicable guideline: observational-study reporting, trial flow and outcomes, or review-method transparency. A revised package should make it easy for the next editor and reviewer to locate the evidence.

Do not treat a checklist as a formality. Make sure the manuscript itself contains the locations and explanations that the checklist points to, and verify the receiving journal's current submission requirements.

Sample sizes that are not justified by the study question. Explain how the sample size relates to the primary outcome, precision, uncertainty, and feasible conclusion. Where the study is exploratory, say so and remove confirmatory claims that the evidence cannot carry.

Ethical approval documentation missing or inadequate. Recheck the ethics committee, consent, registration, data-availability, funding, and conflict disclosures against the receiving journal's current instructions. These are package requirements, not details to fix after submission.

Conclusions overreaching the observational or pilot study design. Cross-sectional, single-centre, pilot, and observational results need language that matches their evidential limits. Revise the abstract, results interpretation, and conclusion together so the new cover letter does not promise more than the paper supports.

Do not use a third-party timing estimate to infer the meaning of a decision or to choose the next journal. BMJ Open's current public statistics report a median 134 days to first decision with review; check the receiving journal's current information separately.